CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

Operating Income Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual operating income in 2023 was 594.67 Million TWD , up 2.17% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 162.17 Million TWD , down -69.2% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported an annual operating income of 582.04 Million TWD in 2022, up 55.86% from previous year.
  • CH Biotech R&D Co., Ltd. reported an annual operating income of 373.43 Million TWD in 2021, up 148.8% from previous year.
  • CH Biotech R&D Co., Ltd. reported a quarterly operating income of 526.5 Million TWD for 2024 Q1, up 804.86% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a quarterly operating income of -74.69 Million TWD for 2023 Q4, down -39.37% from previous quarter.

Annual Operating Income Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 594.67 Million TWD 2.17%
2022 582.04 Million TWD 55.86%
2021 373.43 Million TWD 148.8%
2020 150.09 Million TWD -41.79%
2019 257.83 Million TWD 0.0%

Peer Operating Income Comparison of CH Biotech R&D Co., Ltd.

Name Operating Income Operating Income Difference
Sinon Corporation 1.42 Billion TWD 58.176%
Taiwan Fertilizer Co., Ltd. 2.75 Billion TWD 78.436%
All Cosmos Bio-Tech Holding Corporation 189.89 Million TWD -213.157%